Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.

@article{Chiarelli2014EffectivenessOS,
  title={Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.},
  author={Anna M. Chiarelli and Maegan V. Prummel and Derek Muradali and Vicky Majpruz and Meaghan Horgan and June C. Carroll and Andrea Eisen and Wendy S. Meschino and R. Shumak and Ellen Warner and Linda Rabeneck},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2014},
  volume={32 21},
  pages={
          2224-30
        }
}
PURPOSE The Ontario Breast Screening Program expanded in July 2011 to screen women age 30 to 69 years at high risk for breast cancer with annual magnetic resonance imaging (MRI) and digital mammography. To the best of our knowledge, this is the first organized screening program for women at high risk for breast cancer. PATIENTS AND METHODS Performance measures after assessment were compared with screening results for 2,207 women with initial screening examinations. The following criteria were… 

Figures and Tables from this paper

Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program.

Screening high risk women 30-39 with annual MRI only may be sufficient for cancer detection and should be evaluated further, particularly for mutation carriers; among women 50-69, detection is most effective when mammography is included with annualMRI.

The Breast Cancer Screening and Timing of Breast MRI—Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center

4 of the 11 primary breast cancers detected were identified by screening MRI within the first month after initial visit, which were not detected by previous mammography, suggesting the benefit of initiating MRI immediately after the discovery of genetic risk.

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.

  • C. RiedlN. Luft T. Helbich
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
PURPOSE To evaluate the breast cancer screening efficacy of mammography, ultrasound, and magnetic resonance imaging (MRI) in a high-risk population and in various population subgroups. PATIENTS AND

Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.

MRI is a useful adjunct to mammography for screening in high-risk women, resulting in a significantly higher rate of cancer detection, however, this was found to be at the cost of more imaging and biopsies for lesions that ultimately proved to be benign.

Genetic/Familial High-Risk Screening: MRI Alone?

The aim of this chapter is to provide a comprehensive overview of the role of the different breast imaging modalities, and to determine whether MRI can be used as a single modality in women with a genetic/familial high risk of breast cancer.

Utilization of magnetic resonance imaging in breast cancer screening.

The quality of mri as a screening tool is described and a discussion of the need for a more nuanced approach to the incorporation of mRI into breast cancer screening is discussed.

Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

While nearly half of women at high lifetime breast cancer risk undergo routine screening mammography at a facility with on-site breast MRI availability, supplemental breast MRI remains widely underutilized among those who may benefit from earlier cancer detection.

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

The median follow-up of women with screen-detected breast cancer in the above observational studies now exceeds 10 years, and the long-term breast cancer-free survival in most of these studies is 90% to 95%.
...

References

SHOWING 1-10 OF 43 REFERENCES

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.

The addition of screening ultrasound or MRI to mammography in women at increased risk of breast cancer resulted in not only a higher cancer detection yield but also an increase in false-positive findings.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

MRI appears to be more sensitive than mammography in detecting tumors in women with an inherited susceptibility to breast cancer.

Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study): Final Results

MRI largely outperformed mammography, ultrasonography, and their combination for screening high-risk women below and over 50, including those with previous personal breast cancer.

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

  • C. KuhlS. Schrading H. Schild
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
M mammography alone, and also mammography combined with breast ultrasound, seems insufficient for early diagnosis of breast cancer in women who are at increased familial risk with or without documented BRCA mutation, but if MRI is used for surveillance, diagnosis of intraductal and invasive familial or hereditary cancer is achieved with a significantly higher sensitivity and at a more favorable stage.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

CONTEXT Current recommendations for women who have a BRCA1 or BRCA2 mutation are to undergo breast surveillance from age 25 years onward with mammography annually and clinical breast examination

Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.

Assessment of the effectiveness of breast cancer screening with modalities other than film mammography, specifically DM and MRI, for both pre/perimenopausal and postmenopausal age groups.

American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography

There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography.

Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000

The Ontario Breast Screening Program met or exceeded Canadian targets for most performance measures and the benign to malignant surgical ratio and diagnostic interval improved over the time periods and for women aged 60 to 69.

Screening of women at high risk for breast cancer.